Showing results (81-90 of 172) with videos related to
Sort By:
Pageof 18
International Psychogeriatrics|January 1, 1995
Maintenance therapies for late-life recurrent major depression: research and review circa 1995C F Reynolds, E Frank, J M Perel, et al.Journal of Affective Disorders|June 9, 1999
Effectiveness of treatments for major depression in primary medical care practice: a post hoc analysis of outcomes for African American and white patientsC Brown, H C Schulberg, D Sacco, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1977
Determination of optically active thiopental, thiamylal, and their metabolites in human urineF I Carroll, D Smith, L C Mark, et al.Acta Psychiatrica Scandinavica|January 5, 2006
Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depressionM P Freeman, J R Hibbeln, K L Wisner, et al.The American Journal of Psychiatry|December 1, 1986
Paradoxical effects of amitriptyline on borderline patientsP H Soloff, A George, R S Nathan, et al.Archives of General Psychiatry|February 1, 1977
Clinical implications of imipramine plasma levels for depressive illnessA H Glassman, J M Perel, M Shostak, et al.Psychopharmacology Bulletin|January 1, 1992
Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depressionE Frank, J M Perel, A G Mallinger, et al.Psychopharmacology Bulletin|January 1, 1993
Haloperidol vs. phenelzine in continuation therapy of borderline disorderJ R Cornelius, P H Soloff, A George, et al.Journal of Chromatography. B, Biomedical Applications|June 23, 1995
Quantitative determination of perphenazine and its metabolites in plasma by high-performance liquid chromatography and coulometric detectionJ P Foglia, D Sorisio, M A Kirshner, et al.Life Sciences|October 24, 1983
Amitriptyline sensitization of a serotonin-mediated behavior depends on the passage of time and not repeated treatmentS M Antelman, L A DeGiovanni, D Kocan, et al.Pageof 18